Initial public offerings scheduled to debut next week
Posted February 7, 2020 3:16 pm.
This article is more than 5 years old.
NEW YORK — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
Week of Feb. 10
Avadim Health – Asheville, N.C., 5 million shares, priced $14-$16, managed by Raymond James/SunTrust Robinson Humphrey. Business: Develops and sells topical products for immune, muscular and skin health.
Huize Holding – Shenzhen, China, 4.7 million shares, priced $9.40-$11.40, managed by Citi/CICC. Proposed Nasdaq symbol HUIZ. Business: Operates an online insurance marketplace in China.
Newborn Acquisition – Shanghai, China, 5 million shares, priced at $10, managed by Chardan Capital Markets. Proposed Nasdaq symbol NBACU. Business: Blank check company led by Chinese fund managers targeting businesses in the US and Asia.
Revolution Medicines – Redwood City, Calif., 10 million shares, priced at $10, managed by JP Morgan/Cowen. Proposed Nasdaq symbol RVMD. Business: Phase 1/2 biotech developing targeted cancer therapies using RAS pathway inhibitors.
Zhongchao – Shanghai, China, 3.5 million shares, priced $4-$4.50, managed by Network 1 Financial Securities. Proposed Nasdaq symbol ZCMD. Business: Chinese internet platform providing medical information, education and training.
The Associated Press
